Pular para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Sweet syndrome in a patient wi...
  • Citar
  • Enviar por SMS
  • Enviar por e-mail
  • Imprimir
  • Exportar registro
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Link permanente
Sweet syndrome in a patient with rectal adenocarcinoma and HIV following neoadjuvant chemoradiation

Sweet syndrome in a patient with rectal adenocarcinoma and HIV following neoadjuvant chemoradiation

Detalhes bibliográficos
Principais autores: Kamina Wilkerson, BS, Flora E. Bradley, MD, Ernest Y. Lee, MD, PhD, Jarish N. Cohen, MD, PhD, Aileen Y. Chang, MD
Formato: Artigo
Idioma:English
Publicado em: Elsevier 2024-01-01
coleção:JAAD Case Reports
Assuntos:
capecitabine
chemotherapy
HIV
neutrophilic dermatosis
radiotherapy
rectal adenocarcinoma
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S235251262300437X
  • Itens
  • Descrição
  • Registros relacionados
  • Registro fonte

Internet

http://www.sciencedirect.com/science/article/pii/S235251262300437X

Registros relacionados

  • Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
    por: Balaji Shewalkar, et al.
    Publicado em: (2023-07-01)
  • Lamotrigine-induced Sweet syndrome: Possible new drug association
    por: Gabriel Neely, MD, et al.
    Publicado em: (2020-10-01)
  • NEOADJUVANT THERMOCHEMORADIOTHERAPY USING INTRARECTAL 5-FLUORURACIL IN COMBINED TREATMENT OF RECTAL CANCER
    por: Yu. A. Barsukov, et al.
    Publicado em: (2015-02-01)
  • A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
    por: Chu Matsuda, et al.
    Publicado em: (2023-01-01)
  • Sweet’s syndrome associated with FLT3 inhibition
    por: Riyad N.H. Seervai, MD, PhD, et al.
    Publicado em: (2024-12-01)

Opções de Busca

  • Histórico de buscas
  • Busca Avançada

Encontrar Mais

  • Navegar o acervo
  • Navegar por ordem alfabética
  • Explorar canais
  • Bibliografia Recomendada
  • Novos itens

Precisa de ajuda?

  • Dicas de Busca
  • Serviço de Referência
  • Perguntas Frequentes